Notably, in the cerebrospinal fluids from patients with Alzheimer’s disease, the levels of GSDMD was remarkably higher than those from healthy controls, implying that GSDMD might be a diagnostic biomarker for Alzheimer’s disease (98). This evidence concerns the gene GSDMD and early-onset autosomal dominant Alzheimer disease.